SINOPHARM Group Guangzhou Co., Ltd. announced that it will receive CNY 530,000,000 on April 19, 2017. The transaction will include participation from China National Accord Medicines Corporation Ltd. (SZSE:000028) to maintain its 100% stake in the company after the transaction. The registered capital of the company will increase from CNY 1,000,000,000 to CNY 1,530,000,000. The transaction was approved at the 22nd meeting of the 7th directorate of investor and does not need its shareholders’ approval. The company reported total assets of CNY 6,433,320,000, net assets of CNY 1,238,690,000, and revenue of CNY 15,692,630,000 for the year ended December 31, 2016.